EODData

MEMBERSHIP REGISTER LOG IN

FRA, 9Y4: RYVU THERAPEUTICS ZY-40

19 Jan 2026
LAST:

6.190

CHANGE:
 0.09		OPEN:
6.190		HIGH:
6.190		ASK:
0.000		VOLUME:
271
CHG(%):
1.43		PREV:
6.280		LOW:
6.190		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
19 Jan 266.1906.1906.1906.190271
16 Jan 266.2806.2806.2806.280271
15 Jan 266.3506.3506.3506.350271
14 Jan 266.3406.3406.3406.340271
13 Jan 266.4206.4206.4206.420271
12 Jan 266.5206.5206.5206.520271
09 Jan 266.4306.4306.4306.430271
08 Jan 266.4406.4406.3906.390271
07 Jan 266.3506.3506.3506.350271
06 Jan 266.2906.2906.2906.290271

PROFILE

Name:RYVU THERAPEUTICS ZY-40
About:Ryvu Therapeutics S.A., a clinical-stage drug discovery and development company, engages in developing of small molecule therapies for treatment in oncology in Poland, European Union, and internationally. The company's lead candidate, RVU120, is a CDK8 and CDK19 kinase inhibitor in Phase 2 clinical trial with potential to treat monotheraphy, combination therapy, monotherapy, and myelofibrosis. It also develops SEL24/MEN1703, a dual PIM and FLT3 kinase inhibitor licensed to the Menarini Group that is in study start-up for Phase 2 clinical trial for the treatment of diffuse large b-cell lymphoma and acute myeloid leukemia. In addition, the company's early pipeline candidates include candidates in the areas of kinases, synthetic lethality, immunometabolism, and immuno-oncology. It has collaborations with BioNTech SE to advance small molecule programs to target immune modulation in cancer and other disease areas; Exelixis Inc. for the development of targeted therapies based on Ryvu's STING agonist technology. The company was formerly known as Selvita S.A. and changed its name to Ryvu Therapeutics S.A. in October 2019. Ryvu Therapeutics S.A. was founded in 2007 and is headquartered in Kraków, Poland.
Sector:Healthcare
Industry:Biotechnology
Address:Leona Henryka Sternbacha 2, Kraków, Poland, 30-394
Website:https://ryvu.com
ISIN:PLSELVT00013
LEI:2594003WO9Q9HHAFL031

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-1.25 
PEG Ratio:-0.18 
Price to Sales:7.63 
Price to Book:1.94 
Profit Margin:-1.31 
Operating Margin:-1.38 
Return on Assets:-0.23 
Return on Equity:-0.95 
Revenue:18.5M 
Shares:23.12M 
Market Cap:143.09M 

TECHNICAL INDICATORS

MA5:6.322.0%
MA10:6.362.7%
MA20:6.200.2%
MA50:6.071.9%
MA100:6.230.7%
MA200:6.606.6%
STO14:47.62
RSI14:57.94
WPR14:-52.38
MTM14:0.30
ROC14:0.05 
ATR:0.09 
Week High:6.525.3%
Week Low:6.190.0%
Month High:6.525.3%
Month Low:5.896.6%
Year High:7.9528.5%
Year Low:4.1947.8%
Volatility:54.14